Document:

Trademark License Agreement between Senetek Plc and Skinvera LLC

 Exhibit 10.126 

Trademark License Agreement 

THIS AGREEMENT is entered into this March 10, 2010 (“Effective Date”), by and between Senetek PLC
(“Licensor”), and Skinvera LLC (“Licensee”). 
 WITNESSETH 

WHEREAS, Licensor owns certain trademarks identified in Exhibit A to this Agreement (“Trademarks”);

 WHEREAS, Licensee desires to use the Trademarks within the Territory covered by this Agreement; and 

WHEREAS, Licensor is willing, subject to the terms and conditions of this Agreement, to grant to Licensee the right to use
the Trademarks in connection with and as a condition precedent to the closing of the transactions contemplated by the Asset Purchase Agreement, dated as of the date hereof (the “Asset Purchase Agreement”), by and between the Licensor and
the Licensee, 
 WHEREAS, Licensee is willing, subject to the terms and conditions of this Agreement, to accept such
rights and obligations, in connection with and as a condition precedent to the closing of the transactions contemplated by the Asset Purchase Agreement; 

NOW, THEREFORE, in consideration of the mutual covenants and conditions contained herein and intending to be legally bound,
the parties hereby agree as follows. 
 ARTICLE 1 DEFINITIONS

Affiliate or Affiliates. “Affiliate” or “Affiliates” shall mean any corporation, firm, partnership, or
other entity, whether de jure or de facto, that directly or indirectly owns, is owned by, or is under common ownership with a party to this Agreement to the extent of at least 50 percent of the equity having the power to vote on or direct the
affairs of the entity and any person, firm, partnership, corporation, or other entity actually controlled by, controlling, or under common control with a party to this Agreement. 

Consideration. “Consideration” shall have the meaning set forth in Article 3 hereto. 

Effective Date. “Effective Date” is as defined immediately prior to the Recitals at the beginning of this
Agreement. 
 Licensee. “Licensee” shall mean the entity referred to as such set forth in the preamble
hereto and its Affiliates. 
 Licensor. “Licensor” shall mean the entity referred to as such set forth in
the preamble hereto. 
 Products. “Products” shall mean the products or services identified on Exhibit A.

 Territory. “Territory” shall mean the territory identified on Exhibit A. 

Third Party or Third Parties. “Third Party” or “Third Parties” shall mean any entity other than a party
to this Agreement or an Affiliate. 
 Trademark or Trademarks. “Trademark” or “Trademarks” shall
mean any one of the trademarks listed in Exhibit A hereto. 

 ARTICLE 2 GRANT OF RIGHT TO USE TRADEMARKS

SECTION 2.1. Grant by Licensor. Licensor grants to Licensee the non-exclusive right to use, and Licensee shall use
only, the Trademarks in the Territory in association with the Products. 
 SECTION 2.2. Further Assignments and
Sublicenses. Licensee shall be entitled to assign, sublicense, make available, or otherwise transfer or disclose any right to use, develop, or otherwise enjoy any of the Trademarks without the further consent of Licensor. [TO BE CONFIRMED]

 SECTION 2.3. Quality.

a. Product sold by Licensee or by any person to whom the Licensee makes a further assignment or sublicense in accordance with
Section 2.2 (“Sublicensee”) shall meet the quality control standards and specifications established from time to time by Licensor, including any requirements of applicable regulatory agencies in the Territory. Licensor shall
have the right, at its expense, to audit Licensee’s or Sublicensee’s satisfaction of such quality control quality control standards and specifications from time to time on a reasonable basis and on reasonable prior notice to Licensee or
Sublicensee. 
 b. In the event that quality control of Licensee or Sublicensee falls below Licensor’s
standards and specifications, Licensor shall give Licensee written notice of such failures, and Licensee shall, at its expense and within the reasonable period set out in the notice, take such corrective action as is necessary to restore quality to
the appropriate level. 
 ARTICLE 3 CONSIDERATION. As consideration for the rights granted under this
Agreement, Licensee has entered into the Asset Purchase Agreement and has agreed to pay the consideration set forth in the Asset Purchase Agreement (“Consideration”). 

ARTICLE 4 WARRANTIES AND REPRESENTATIONS

SECTION 4.1. Of Licensor. Licensor warrants that 

a. It owns the exclusive right, title, and interest in each Trademark for the Territory; 

b. Each Trademark is valid and enforceable in the Territory; 

c. Use of any Trademark does not infringe on any rights of Third Parties; and 

d. It has the right and authority to enter into this Agreement. 

SECTION 4.2. Of Licensee. Licensee warrants that it has the right and authority to enter into this Agreement.

 ARTICLE 5 TRADEMARK OWNERSHIP

SECTION 5.1. Legal Ownership. Licensee acknowledges Licensor’s exclusive legal right, title, and interest in
and to all Trademarks. Licensee shall not at any time do or cause to be done, or fail to do or cause to be done, any act or thing, directly or indirectly, contesting or in any way impairing Licensor’s right, title, or interest in any Trademark.
Every use of any Trademark by Licensee shall inure to the benefit of Licensor. 

 ARTICLE 6 TERM AND TERMINATION

SECTION 6.1. Term. Subject to Section 6.2, this Agreement shall remain in effect as of the Effective Date
until the eighteen month anniversary thereafter. 
 SECTION 6.2. Termination. Neither party shall have
the right to terminate this Agreement at any time, absent the occurrence of any of the following events: 
 a. Failure or neglect of a party to
perform covenants or provisions of this Agreement if such default is not corrected within 30 days after receiving written notice from the other party with respect to such default; 

b. Any act, determination, filing, judgment, declaration, notice, appointment of receiver or trustee, failure to pay debts, or other events under any law
applicable to a party indicating the insolvency or bankruptcy of such party; or 
 c. Any extraordinary governmental action, including, without
limitation, seizure or nationalization of assets, stock, or other property relating to a party. 
 SECTION
6.3. Rights and Duties Upon Termination. On termination of this Agreement, 
 a. Licensor shall have the right to retain or
receive the Consideration as applicable; and 
 b. Licensee shall discontinue all use of any Trademark and shall have no further right, title,
or interest in any Trademark. 
 ARTICLE 7 MISCELLANEOUS

SECTION 7.1. Notices. Any and all notices, elections, offers, acceptances, and demands permitted or required to be
made under this Agreement shall be in writing, signed by the person giving such notice, election, offer, acceptance, or demand and shall be delivered personally, or sent by registered or certified mail, with a copy by facsimile, to the party,
addressed as follows: 
 If to Licensor: 

Senetek plc 
 301
Central Ave, #384 
 Hilton Head, South Carolina 29926 

Attention: John Ryan 

Tel: 842.290.8930 

Fax: 843.842.7248 

Email: jryan@senetek.net 

If to Licensee: 

Skinvera LLC 

2951 Marion Drive, Unit # 121 

Las Vegas, NV 89115 

Attention: Frank Massino 

Tel: 842.290.8930 

Fax: 843.842.7248 

Email: jryan@senetek.net 

 The date of personal delivery or the date of mailing, as the case may be, shall be
the date of such notice, election, offer, acceptance, or demand. 
 SECTION 7.2. Force Majeure. If the
performance of any part of this Agreement by either party, or of any obligation under this Agreement, is prevented, restricted, interfered with, or delayed by reason of any cause beyond the reasonable control of the party liable to perform, unless
conclusive evidence to the contrary is provided, the party so affected shall, on giving written notice to the other party, be excused from such performance to the extent of such prevention, restriction, interference, or delay, provided that the
affected party shall use its reasonable best efforts to avoid or remove such causes of nonperformance and shall continue performance with the utmost dispatch whenever such causes are removed. When such circumstances arise, the parties shall discuss
what, if any, modification of the terms of this Agreement may be required to arrive at an equitable solution. 
 SECTION
7.3. Binding Effect, Assignment, Etc. This Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their permitted assigns and successors-in-interest. Neither party may assign any right, or
delegate any obligation hereunder without the express prior written consent of the other, which consent shall be strictly at the discretion of such other party and may be contingent, if given, upon such terms and conditions as it sees fit.

 SECTION 7.4. Amendment. No change, modification, or amendment of this Agreement shall be valid or
binding on the parties unless such change or modification shall be in writing signed by the parties hereto. 
 SECTION
7.5. Remedies Cumulative. The remedies of the parties under this Agreement are cumulative and shall not exclude any other remedies to which the party may be lawfully entitled. 

SECTION 7.6. Further Assurances. Each party hereby covenants and agrees that it shall execute and deliver such
deeds and other documents as may be required to implement any of the provisions of this Agreement. 
 SECTION
7.7. No Waiver. The failure of any party to insist on strict performance of a covenant hereunder or of any obligation hereunder shall not be a waiver of such party’s right to demand strict compliance therewith in the
future, nor shall the same be construed as a novation of this Agreement. 
 SECTION
7.8. Integration. This Agreement, together with the Asset Purchase Agreement, constitute the full and complete agreement of the parties. 

SECTION 7.9. Captions. Titles or captions of articles and sections contained in this Agreement are inserted only
as a matter of convenience and for reference, and in no way define, limit, extend, or describe the scope of this Agreement or the intent of any provision hereof. 

SECTION 7.10. Number and Gender. Whenever required by the context, the singular number shall include the plural,
the plural number shall include the singular, and the gender of any pronoun shall include all genders. 
 SECTION
7.11. Counterparts. This Agreement may be executed in multiple copies, each of which shall for all purposes constitute an Agreement, binding on the parties, and each partner hereby covenants and agrees to execute all duplicates
or replacement counterparts of this Agreement as may be required. Facsimile or .pdf signatures shall be deemed originals for all purposes hereunder. 

 SECTION 7.12. Computation of Time. Whenever the last day for the
exercise of any privilege or the discharge of any duty hereunder shall fall on a Saturday, Sunday, or any public or legal holiday, whether local or national, the person having such privilege or duty shall have until 5:00 p.m. in New York, New York
(USA) on the next succeeding business day to exercise such privilege, or to discharge such duty. 
 SECTION
7.13. Costs and Expenses. Unless otherwise provided in this Agreement, each party shall bear all fees and expenses incurred in performing its obligations under this Agreement. 

SECTION 7.14. Governing Law, Jurisdiction, Etc. This Agreement shall be governed by, and construed in accordance
with, the laws of the State of New York applicable to contracts performed wholly within New York. 
 IN WITNESS
WHEREOF, the parties hereto have caused this Agreement to be executed on the date first written above by their duly authorized officers. 
  

	
	SENETEK PLC
	
	  
	Name: John Ryan
	Title: Chief Executive Officer
	
	SKINVERA LLC
	
	  
	Name: Frank Massino
	Title: Manager

 EXHIBIT A 

 

	I.	Trademarks 

 SenetekCollateral Pledge and Security Agreement between Senetek Plc and Skinvera LLC

 Exhibit 10.127 

COLLATERAL PLEDGE AND SECURITY AGREEMENT 

This COLLATERAL PLEDGE AND SECURITY AGREEMENT (this “Agreement”), dated as of March     , 2010, by
and between Skinvera LLC, a Nevada limited liability company (the “Company”), and Senetek plc, a corporation organized under the laws of England (the “Holder”). 

Pursuant to that certain Asset Purchase Agreement, dated as of even date herewith (the “Purchase Agreement”), between the
Company and the Holder, the Holder has extended credit or will extend credit to the Company represented by a promissory note (the “Note”) in the aggregate principal amount of $1,800,000. To induce the Holder to extend credit to the
Company, the Company has agreed to grant a security interest in certain collateral to the Holder; 
 In consideration of the
foregoing premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Holder agree as follows: 

1. Certain Definitions. The following terms shall have the following meanings (such meanings to be equally applicable to both the
singular and plural forms of the terms defined): 
 “Account” shall have the meaning ascribed to such term in
Section 9-102 of the UCC. 
 “Chattel Paper” shall have the meaning ascribed to such term in
Section 9-102 of the UCC. 
 “Collateral” shall have the meaning specified in Section 2 hereof.

 “Company” shall have the meaning specified in the preamble hereto. 

“Note” shall have the meaning specified in the Recitals hereto. 

“Document” shall have the meaning ascribed to such term in Section 9-102 of the UCC. 

“Effective Date” means the date of the Note, unless the proceeds of the Note are held in escrow pending the
satisfaction of certain conditions or the occurrence of certain events, in which case, the Effective Date shall be the date as of which such proceeds are released from escrow. 

“Equipment” shall have the meaning ascribed to such term in Section 9-102 of the UCC. 

“Event of Default” shall have the meaning specified in Section 8 hereof. 

 “Governmental Authority” shall mean any federal, state, local, foreign or
other governmental or administrative (including self-regulatory) body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute resolving panel or body and
shall include any “governmental unit” as such term is defined in Section 9-102 of the UCC. 

“Holder” shall have the meaning specified in the Preamble hereto. 

“Instrument” shall have the meaning ascribed to such term in Section 9-102 of the UCC. 

“Inventory” shall have the meaning ascribed to such term in Section 9-102 of the UCC. 

“Lien” shall mean any mortgage, pledge, assignment, security interest, encumbrance, lien or charge of any kind, any
conditional sale or other title retention agreement or any lease in the nature thereof (including any agreement to give any of the foregoing). 

“Obligations” shall have the meaning specified in Section 3 hereof. 

“Permitted Liens” shall have the meaning set forth in the Purchase Agreement. 

“Person” shall have the meaning ascribed to such term in Section 9-102 of the UCC and shall include any individual,
partnership, joint venture, firm, corporation, limited liability company, limited liability partnership, association, trust or other enterprise or any Governmental Authority. 

“Proceeds” shall have the meaning ascribed to such term in Section 9-102 of the UCC and shall include, without
limitation, (a) any and all payments (in any form whatsoever) made or due and payable to the Company from time to time in connection with any condemnation, seizure or forfeiture of all or any part of the Collateral by any Governmental
Authority), (b) any and all amounts paid or payable to the Company for or in connection with any sale or other disposition of all or any part of the Collateral and (c) any and all other amounts from time to time paid or payable under or in
connection with any of the Collateral. 
 “Purchase Agreement” shall have the meaning specified in the Recitals
hereto. 
 “Receivables” shall mean all Accounts, Documents, Instruments and Chattel Paper. 

“UCC” shall mean the Uniform Commercial Code as in effect in the State of New York from time to time. 

2. Grant of a Security Interest. As security for the prompt and complete payment and performance when due of all the Obligations,
as of the Effective Date, the Company hereby pledges, assigns, transfers and grants to the Holder, a continuing first-priority security interest in those assets purchased by the Company from Senetek pursuant to the Asset Purchase Agrement with
Senetek PLC, dated as of the date hereof (collectively, “Collateral”): 
  

 -2- 

 3. The Company’s Obligations Secured Hereby. This Agreement secures, and the
Collateral is collateral security for, the prompt payment and performance in full when due by acceleration of all obligations of the Company under or in respect of the Note (including, without limitation, the Company’s obligations to pay
principal and all other charges, fees, expenses, commissions, reimbursements, indemnities and other payments related to or in respect of the obligations contained in the Note) following an Event of Default (as such term is defined in the Note)
occurring at any time, or from time to time, during the term of this Agreement (collectively, the “Obligations”). 

4. No Release. During the term of this Agreement nothing set forth in this Agreement shall relieve the Company from the
performance of any term, covenant, condition or agreement on the Company’s part to be performed or observed under or in respect of any of the Collateral or from any liability to any Person under or in respect of any of the Collateral or impose
any obligation on the Holder to perform or observe any such term, covenant, condition or agreement on the Company’s part to be so performed or observed or shall impose any liability on the Holder for any act or omission on the part of the
Company relating thereto or for any breach of any representation or warranty on the part of the Company contained in the Note or this Agreement, or in respect of the Collateral or made in connection herewith or therewith. 

5. The Company’s Representations and Warranties. The Company represents and warrants and, so long as this Agreement is in
effect, shall be deemed continuously to represent and warrant, that: 
 (a) Authority; Enforceability. The Company has
full organizational power and authority and has taken all organizational action necessary to execute, deliver and perform this Agreement and the Note and to encumber and grant a security interest in the Collateral. This Agreement constitutes legal,
valid and binding obligations of the Company, enforceable against the Company in accordance with its terms. 
 (b) Security
Interest; Necessary Filings. This Agreement creates a valid security interest of the Holder in the Collateral securing payment of the Obligations. All filings, registrations and recordings necessary, appropriate or reasonably requested by the
Holder to create, preserve, protect and perfect the security interest granted by the Company to the Holder hereby in respect of the Collateral have or will be made on or before the date of this Agreement. The security interest granted to the Holder
pursuant to this Agreement in and to the Collateral constitutes and hereafter will constitute a perfected security interest therein. 

(c) No Consents, etc. No other consent of any other Person (including, without limitation, members or creditors of the Company)
and no consent, authorization, approval, or other action by, and no notice to or filing with, any Governmental Authority (other than a court in connection with the exercise of judicial remedies by the Holder) or regulatory body is required either
(i) for the pledge by the Company of the Collateral pursuant to this Agreement, or for the execution, delivery or performance of this Agreement by the Company, or (ii) for the exercise by the Holder of the rights provided for in this
Agreement or the remedies in respect of the Collateral pursuant to this Agreement. 
  

 -3- 

 (d) The Company’s Tax and Organizational Identification Numbers. The
Company’s tax identification number is 27-1881499. 
 (e) Collateral. All information set forth herein relating
to the Collateral is accurate and complete in all material respects. 
 (f) Additional Representations, Warranties and
Covenants of the Company. The Company hereby repeats each of the representations and warranties made by the Company and contained or incorporated by reference in the Note as fully as if each such representation and warranty were expressly set
forth herein and expressly made herein by the Company on and as of the date hereof, each such representation and warranty being incorporated in this Agreement by reference mutatis mutandis. 

6. The Company’s Covenants. The Company agrees and covenants for itself, its successors and permitted assigns that:

 (a) Business Use; Protection of the Holder’s Security. The Collateral will be used for business purposes of the
Company and will remain in the possession or under the control of the Company and will not be used for any unlawful purpose. 

(b) Financing Statements. As promptly as practicable after the execution and delivery of this Agreement, the Company shall file a
UCC-1 Financing Statement. 
 (c) Further Actions. The Company shall at any time and from time to time take such steps as
the Holder may reasonably request to insure the continued perfection and priority of the Holder’s security interest in any of the Collateral and of the preservation of its rights therein in any jurisdiction. 

(d) Protection of the Holder’s Security. The Company shall at all times keep the Inventory and Equipment insured by
financially sound and reputable insurers and with such deductibles as would be maintained by operators of businesses similar to the business of the Company. 

(e) Maintenance of Equipment. The Company shall cause the Equipment to be maintained and preserved in the same condition, repair
and working order as when new, ordinary wear and tear excepted, and to the extent consistent with past business practice in accordance with any manufacturer’s manual, and shall forthwith as quickly as practicable after the occurrence thereof,
make or cause to be made all repairs, replacements and other improvements in connection therewith which are necessary or desirable to such end. 

(f) Payment of Taxes: Claims. The Company shall pay promptly when due all property and other taxes, assessments and governmental
charges or levies (other than those the Company is contesting in good faith and with respect to which it has made sufficient reserves on its financial statements) imposed upon, and all claims (including claims for labor, materials and supplies)
against, the Collateral. 
  

 -4- 

 (g) Ordinary Course of Business. Subject to any limitation contained in the Note,
nothing in this Section 6 shall be deemed to prohibit (i) the sale of Inventory and the collection of Receivables by the Company in the ordinary course of business and (ii) the disposition and replacement of obsolete assets as
necessary in the ordinary course of the Company’s business. 
 7. Reasonable Care. The Holder shall be deemed to
have exercised reasonable care in the custody and preservation of Collateral in its possession if such Collateral is accorded treatment substantially equivalent to that which the Holder, in its individual capacity, accords its own property, it being
understood that the Holder shall not have responsibility for taking any necessary steps to preserve rights against any Person with respect to any Collateral. 

8. Events of Default. The occurrence of an “Event of Default” under the Note shall constitute an “Event of
Default” under this Agreement. 
 9. Remedies. 

(a) Acceleration of Note. Upon the occurrence of an Event of Default, the Holder may, by notice to the Company, declare the
aggregate unpaid principal balance of all the Note, to be immediately due and payable and thereupon all such amounts shall be and become immediately due and payable to the Holder. 

(b) Obtaining the Collateral Upon Event of Default. If any Event of Default shall have occurred and be continuing, then and in
every such case, the Holder may, at any time or from time to time during the continuance of such Event of Default take any or all of the following actions, all if which shall be at the Company’s expense, which expenses shall constitute
Obligations secured by the Collateral: 
 (i) Personally, or by agents or attorneys, immediately take possession of the
Collateral or any part thereof from the Company or any other Person who then has possession of any part thereof, with or without notice or process of law, and for that purpose may enter upon the Company’s premises where any of the Collateral is
located and remove such Collateral, and use in connection with such removal any and all services, supplies, aids and other facilities of the Company; 

(ii) Instruct the obligor or obligors on any agreement, instrument or other obligation constituting the Collateral, to make any payment
required by the terms of such agreement, instrument or other obligation directly to the Holder; provided, however, in the event that any such payments are made directly to the Company, the Company shall hold such payments in trust and
shall segregate all amounts received pursuant thereto in a separate account and pay the same promptly to the Holder; 
 (iii)
Sell, assign or otherwise liquidate, or direct the Company to sell, assign or otherwise liquidate, the Collateral, or any part thereof, and take possession of the proceeds of any such sale, assignment or liquidation; and/or 

(iv) Take possession of the Collateral, or any part thereof, by directing the Company in writing to deliver the same to the Holder at
any place or places designated by the Holder, in which event the Company shall at its own expense: (A) forthwith cause the same to be moved to the place or places so designated by the Holder and there delivered to the Holder;
(B)
  

 -5- 

 
store and keep any Collateral so delivered to the Holder at such place or places pending further action by the Holder; and (C) while the Collateral shall be so stored and kept, provide such
guards and maintenance services as shall be necessary to protect the same and to preserve and maintain them in good condition. The Company’s obligation to deliver the Collateral is of the essence of this Agreement. Upon application to a court
of equity having jurisdiction, the Holder shall be entitled to a decree requiring specific performance by the Company of such obligation. 

(c) Other Rights and Remedies. Upon the occurrence and during the continuance of an Event of Default, the Holder may from time to
time exercise in respect of the Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a secured party under the UCC at the time of an Event of Default. 

(d) Waiver of Claims. Except as otherwise provided herein, the Company hereby waives, to the fullest extent permitted by
applicable law, notice or judicial hearing in connection with the Holder’s taking possession, or the Holder’s disposition of any of the Collateral, including, without limitation, any and all prior notice and hearing for any prejudgment
remedy or remedies and any such right which the Company would otherwise have under law, and the Company hereby further waives to the extent permitted by applicable law: (i) all damages occasioned by such taking of possession, (ii) all
other requirements as to the time, place and terms of sale or other requirements with respect to the enforcement of the Holder’s rights hereunder, and (iii) all rights of redemption, appraisal, valuation, stay, extension or moratorium now
or hereafter in force under any applicable law. Any sale of, or the grant of options to purchase, or any other realization upon, any Collateral shall operate to divest all rights, title, interest, claim and demand, either at law or in equity, of the
Company therein and thereto, and shall be a perpetual bar both at law and in equity against the Company and against any and all Persons claiming or attempting to claim the Collateral so sold, optioned or realized upon, from, through or under the
Company. 
 (e) Notice. Without in any way requiring notice to be given in the following time and manner, the Company
agrees that any notice by the Holder of sale, disposition or other intended action hereunder or in connection herewith, whether required by the UCC or otherwise, shall constitute reasonable notice to the Company if such notice is delivered in
accordance with Section 15(h) hereof and is given at least five business days prior to the intended action which is the subject matter thereof. 

10. Payments After an Event of Default. All payments received and amounts realized by the Holder pursuant to Section 9,
including all such payments and amounts received after the entire unpaid principal amount of the Note has been declared due and payable, as well as all payments or amounts then held or thereafter received by the Holder as part of the Collateral
while an Event of Default shall be continuing, shall be promptly applied and distributed by the Holder in the following order of priority: 

(a) first, to the payment of all costs and expenses, including reasonable legal expenses and attorneys’ fees for one counsel
in each jurisdiction in which counsel may be required, incurred or made hereunder or under the Note by the Holder, whether or not constituting Obligations, including, without limitation, any such costs and expenses of

  

 -6- 

 
foreclosure or suit, if any, and of any sale or the exercise of any other remedy under Section 9, and of all taxes, assessments or liens superior to the lien granted under this Agreement,
except any taxes, assessments or other superior lien subject to which any said sale under Section 9 hereof may have been made; and 

(b) second, to the payment to the Holder of the amount then owing or unpaid on the Note; and 

(c) third, to the payment of the balance or surplus, if any, to the Company, its successors and assigns, or to whomsoever may be
lawfully entitled to receive the same. 
 11. The Holder’s Right to Cure; Reimbursement. In the event the Company
should fail to do any act as herein provided, the Holder may, but without obligation to do so, without notice to the Company, and without releasing the Company from any obligation hereof, make or do the same in such manner and to such extent as the
Holder may deem necessary to protect the Collateral, including, without limitation, the defense of any action purporting to affect the Collateral or the rights or powers of the Holder hereunder, at the Company’s expense. The Company shall
reimburse the Holder for expenses reasonably incurred under this Section 11 and any such expenses not reimbursed will constitute Obligations secured by the Collateral. 

12. Expenses. The Company will upon demand pay to the Holder the amount of any and all reasonable expenses, including the fees and
expenses of its counsel and the allocated fees and expenses of staff counsel and the fees and expenses of any experts and agents, which the Holder may incur in connection with (a) the collection of the Obligations, (b) the administration
of this Agreement, (c) the custody or preservation of, or the sale of, collection from, or other realization upon, any of the Collateral, (d) the exercise or enforcement of any of the rights of the Holder hereunder, or (e) the failure
by the Company to perform or observe any of the provisions hereof. All amounts payable by the Company under this Section 12 shall be due upon demand and shall be part of the Obligations. The Company’s obligations under this Section 12
shall survive the termination of this Agreement and the discharge of the Company’s other obligations hereunder. 
 13.
Termination; Release. This Agreement shall terminate on the satisfaction in full of all of the Obligations and, on such termination, the Holder shall release to the Company the security interest granted in the Collateral hereunder and, upon
the request and at the expense of the Company, forthwith assign, transfer and deliver to the Company, against receipt and without recourse to or warranty by the Holder, such of the Collateral to be released as may then be in the possession of the
Holder and proper instruments acknowledging the termination of this Agreement or the release of such Collateral, as the case may be; provided, that if, after receipt of any payment of all or any part of the Obligations, the Holder is for any reason
compelled to surrender such payment to any person or entity because such payment is determined to be void or voidable as a preference, impermissible setoff, or a diversion of trust funds, or for any other reason, this Agreement shall continue in
full force notwithstanding any contrary action which may have been taken by the Holder in reliance upon such payment, and any such contrary action so taken shall be without prejudice to the Holder’s rights under this Agreement and shall be
deemed to have been conditioned upon such payment having become final and irrevocable. 
  

 -7- 

 14. Miscellaneous. 

(a) Entire Agreement; Amendment. This Agreement, the Purchase Agreement and the Note set forth the entire understanding of the
parties with respect to the subject matter hereof and supersede all existing agreements among them concerning such subject matter. This Agreement may only be amended or modified by a written instrument duly executed by the Company and the Holder.

 (b) Successors and Assigns. This Agreement, together with the covenants and warranties contained in it, shall inure to
the benefit of the Holder, the Holders and their respective successors, assigns, heirs and personal representatives, and shall be binding upon the Company, its successors and permitted assigns; provided, that the Company may not assign this
Agreement without the prior written consent of the Holder. No other Persons (including, without limitation, any other creditor of the Company) shall have any interest herein or any right or benefit with respect hereto. Without limiting the
generality of the foregoing, the Holder may assign or otherwise transfer any indebtedness held by it and secured by this Agreement to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof
granted to such the Holder, herein or otherwise, subject, however, to the provisions of the Note. 
 (c) No Waiver;
Cumulative Remedies. No failure on the part of the Holder to exercise, no course of dealing with respect to, and no delay on the part of the Holder in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall
any single or partial exercise of any such right, power or remedy hereunder preclude any other or further exercise thereof or the exercise of any other right, power or remedy. The remedies herein provided are cumulative and are not exclusive of any
remedies provided by law. In the event the Holder shall have instituted any proceeding to enforce any right, power or remedy under this Agreement by foreclosure, sale, entry or otherwise, and such proceeding shall have been discontinued or abandoned
for any reason or shall have been determined adversely to the Holder, then and in every such case, the Company and the Holder shall be restored to their respective former positions and rights hereunder with respect to the Collateral, and all rights,
remedies and powers of the Holder shall continue as if no such proceeding had been instituted. 
 (d) Governing Law. This
Agreement shall be governed by, and shall be construed and enforced in accordance with, the laws of the State of New York. 

(e) Consent to Jurisdiction and Service of Process. The Company irrevocably consents to the jurisdiction of the courts of New York
County, New York in connection with any action or proceeding arising out of or relating to this Agreement, any document or instrument delivered pursuant to, in connection with or simultaneously with this Agreement, or a breach of this Agreement or
any such document or instrument. In any such action or proceeding, the Company waives personal service of any summons, complaint or other process and agrees that service thereof may be made in accordance with Section 15(h). Nothing herein shall
affect the right to serve process in any other manner permitted by law or shall limit the right of the Holder to bring proceedings against the Company in the courts of any other jurisdiction. 

 

 -8- 

 (f) WAIVER OF JURY TRIAL. DEBTOR HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL
PROCEEDING TO WHICH IT IS A PARTY INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER.

 (g) Severability of Provisions. If any provision of this Agreement is invalid, illegal or unenforceable, the balance
of this Agreement shall remain in effect, and if any provision is inapplicable to any person, party or circumstance, it shall nevertheless remain applicable to all other persons, parties and circumstances. 

(h) Notices. All notices and other communications required or permitted under this Agreement shall be sent by registered or
certified mail, postage prepaid, overnight courier, confirmed telex or facsimile transmission (provided, that a copy is also set by registered or certified mail), or delivered by hand or by messenger, addressed: 

 

			
	If to the Company	  	
	or any Subsidiary:	  	Skinvera LLC
		  	2951 Marion Drive, Unit #121
		  	Las Vegas, NV 89115
		  	Attention: Manager
		
	If to Holder:	  	Senetek plc
		  	301 Central Ave, #384
		  	Hilton Head, South Carolina 29926
		  	Attention : John Ryan
		  	Tel: 842.290.8930
		  	Fax: 843.842.7248
		  	Email: jryan@senetek.net
		
	With a copy to:	  	DLA Piper LLP
		  	1251 Avenue of the Americas
		  	New York, New York 10020-1104
		  	Attention: William N. Haddad
		  	Tel: 212.335.4998
		  	Fax: 212.884.8498
		  	Email: william.haddad@dlapiper.com

or, in either case, to such other address as the party shall have furnished in writing in accordance with the provisions of this
Section 6.3. Any notice given by means other than as set forth above shall be deemed effective upon receipt. 
  

 -9- 

 (i) Execution in Counterparts. This Agreement and any amendments, waivers, consents
or supplements hereby may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed to be an original, but all such counterparts together shall
constitute one and the same agreement. Facsimile signatures shall be deemed originals for all purposes hereunder. 
 (j)
Headings. The Section headings used in this Agreement are for convenience of reference only and shall not affect the construction or interpretation of this Agreement. 

[Remainder of page left intentionally blank. Signature page follows] 

 

 -10- 

 IN WITNESS WHEREOF, the parties have executed this Collateral Pledge and Security
Agreement on the date set forth above. 
  

			
	SENETEK PLC
		
	By:	 	  

	Name:	 	John Ryan
	Title:	 	Chief Executive Officer
	
	SKINVERA LLC
		
	By:	 	  

	Name:	 	Frank Massino
	Title:	 	Manager

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]